Not applicableStudy completedNCT00960609What this trial is testingCommunicating Veins Between Adjacent Hepatic Veins: an Intra-operative Ultrasound StudyWho this might be right forLiver Tumors University of Milan
Testing effectiveness (Phase 2)WithdrawnNCT01157039What this trial is testingA Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of OxaliplatinWho this might be right forColorectal CarcinomaNeoplasms, ColorectalColorectal Cancer+2 more AHS Cancer Control Alberta
Not applicableLooking for participantsNCT06227728What this trial is testingAnalysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.Who this might be right forNon Small Cell Lung CancerBreast CancerColorectal Cancer+4 more Gene Solutions 50
Testing effectiveness (Phase 2)Study completedNCT03993353What this trial is testingTadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck CancerWho this might be right forHead and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Carcinoma+9 more University of California, San Diego 7
Not applicableNot Yet RecruitingNCT07689812What this trial is testingRandomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Who this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more Natera, Inc. 920
Testing effectiveness (Phase 2)Study completedNCT01806675What this trial is testing18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Study completedNCT00102700What this trial is testingARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic CancerWho this might be right forPancreatic CancerAdenocarcinoma ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 66
Testing effectiveness (Phase 2)Ended earlyNCT03320629What this trial is testingApatinib Plus Radiotherapy and S-1 for Treatment of Refractory or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forRefractory or Metastatic Esophageal Squamous Cell Carcinoma Hebei Medical University Fourth Hospital 7
Early research (Phase 1)Ended earlyNCT04975256What this trial is testingAdagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)Who this might be right forAdvanced CancerMetastatic CancerMalignant Neoplasm of Colon+2 more Mirati Therapeutics Inc. 7
Testing effectiveness (Phase 2)UnknownNCT01348256What this trial is testingStudy With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal CarcinomaWho this might be right forColorectal CarcinomaHepatic Metastasis Clinica Universidad de Navarra, Universidad de Navarra 58
Testing effectiveness (Phase 2)Study completedNCT02307500What this trial is testingRegorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard TherapyWho this might be right forPancreas CancerOvarian CancerMelanoma+4 more Istituto Clinico Humanitas 82
Early research (Phase 1)Study completedNCT01385956What this trial is testingSOM 230 and Gemcitabine in Advanced Pancreatic CancerWho this might be right forPancreatic Cancer H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)UnknownNCT03927495What this trial is testingKN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Shanghai Chest Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT07174570What this trial is testingCelecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver CancerWho this might be right forAdvanced Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+1 more Emory University 39
Testing effectiveness (Phase 2)Ended earlyNCT01774851What this trial is testingMM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and StomachWho this might be right forHER-2 Gene AmplificationEsophagus CancerGastroesophageal Junction Cancer+1 more Merrimack Pharmaceuticals 84
Testing effectiveness (Phase 2)Study completedNCT01834469What this trial is testingImaging of Peritoneal Carcinomatosis From Ovarian Carcinoma PatientsWho this might be right forOvarian CancerPeritoneal Carcinomatosis Jules Bordet Institute 10
Not applicableActive Not RecruitingNCT05524012What this trial is testingLongitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal CancerWho this might be right forLocally Advanced Rectal CarcinomaNeoadjuvant TreatmentRadiotherapy+1 more Jena University Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT05863195What this trial is testingTesting Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialWho this might be right forMetastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverStage IV Colorectal Cancer AJCC v8+1 more ECOG-ACRIN Cancer Research Group 408
Testing effectiveness (Phase 2)Ended earlyNCT03301454What this trial is testingStudy of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal CancerWho this might be right forEsophageal Cancer, Squamous Cell Centre Oscar Lambret 15
Testing effectiveness (Phase 2)Looking for participantsNCT06906562What this trial is testingA Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic AlterationsWho this might be right forAdvanced Pancreatic CarcinomaMetastatic Pancreatic CarcinomaStage II Pancreatic Cancer AJCC v8+2 more Sameek Roychowdhury 40